人胞內(nèi)細(xì)胞因子檢測刺激方案
 |
| 人細(xì)胞因子 | 細(xì)胞來源 | 活化-極化培養(yǎng) | 培養(yǎng)時間 | 再次刺激 | 胞內(nèi)阻斷劑 |
| G-CSF | PBMC | LPS (1 ug/mL) | 24hr | - | Monensin |
| GM-CSF | PBMC | PMA (30-50ng/mL)/Iono (1ug/mL) | 5hr | - | Monensin |
| GIFN gamma | PBMC | PMA (30-50ng/mL)/Iono (1ug/mL) | 5hr | - | Brefeldin A |
| IL-1 alpha | PBMC | LPS (1 ug/mL) | 24hr | - | Monensin |
| IL-1 beta | PBMC | LPS (100ng/mL) | 4hr | - | Brefeldin A |
| IL-1RA | PBMC | LPS (100ng/mL) | 24hr | - | Brefeldin A |
| IL-2 | PBMC | PMA (30-50ng/mL)/Iono (1ug/mL) | 4-6hr | - | Brefeldin A |
| IL-4 | PBMC | PMA (30-50ng/mL)/Iono (1ug/mL) | 4-6hr | - | Brefeldin A |
| IL-5 | CD4 | Th2 polarizing cultures | 6d | PMA (50ng/mL) + Ionomycin (1ug/mL) (5hr) | Brefeldin A |
| IL-6 | PBMC | LPS (100ng/mL) | 24hr | - | Brefeldin A |
| IL-9 | CD4 | h2 polarizing culturesT | 6d | PMA (50ng/mL) + Ionomycin (1ug/mL) (5hr) | Monensin |
| IL-10 | CD4 | Th2 polarizing cultures | 6d | PMA (50ng/ml) + Ionomycin (1ug/ml) (5hr) | Monensin |
| IL-12/ IL-23 (p40) | PBMC |
hIFN gamma (100ng/mL) (2hr)/LPS (100ng/mL) (22hr) | 2hr/22hr | - | Brefeldin A |
| IL-13 | CD4 | anti-CD3 (10ug/mL, immobilized) + anti-CD28 (2ug/mL, soluble) + IL-2 (10ng/mL) + IL-4 (20ng/mL) (2d); IL-2 (10ng/mL) + IL-4 (20ng/mL) (3d) | 2d/3d | PMA (5ng/ml) + Ionomycin (500ng/ml) (4hr) | Brefeldin A |
| IL-17A | PBMC | PMA (30-50ng/mL)/Iono (1ug/mL) | 5hr | - | Monensin |
| IL-21 | PBMC | PMA (30-50ng/mL)/Iono (1ug/mL) | 4-7hr or 12-18hr | - | Brefeldin A |
| IL-22 | CD4 | Th17 polarizing cultures | 6d | PMA (50ng/ml) + Ionomycin (1ug/ml) (5hr) | Brefeldin A |
| IL-23 p19 | PBMC | hGM-CSF (40ng/mL) +hIL-4 (40ng/mL) | 6d | LPS (1ug/mL) (24hr) | Monensin |
| MCP-1/ CCL2 | PBMC | LPS (1ug/mL) | 24hr | - | Monensin |
| RANTES/ CCL5 | PBMC | LPS (1ug/mL) | 24hr | - | Monensin |
| TNF alpha | PBMC | PMA (30-50ng/mL)/Iono (1ug/mL) | 5hr | - | Brefeldin A |
| TNF beta | PBMC | Th1 polarizing cultures | 6d | PMA (50ng/mL) + Ionomycin (1ug/mL) (5hr) | Monensin |
|
注： PBMC=外周血單核細(xì)胞peripheral blood mononuclear cell；PMA=佛波酯Phorbol Myristate Acetate; calcium ionophore; 鈣離子載體 iono=離子霉素ionomycin; LPS=脂多糖Lipopolysaccharide; 4hr=4 hours culture; 2d=2 days culture. GolgiStop/GolgiPlug: 一種胞內(nèi)阻斷劑，可以用BFA/Monensin替代。
| |||||
 |
閱讀原文：http://www.liankebio.com/TechServiceShow/articleID/2014060019.html
- CRM197白喉毒素?zé)o毒突變體作為載體蛋白在疫苗中的應(yīng)用及臨床表現(xiàn)
- 線粒體超氧化物指示劑的原理及實驗應(yīng)用技術(shù)詳解
- 細(xì)胞因子的分子特征、作用機(jī)制及其在疾病研究中的臨床價值
- 趨化因子超家族及其受體的分子特征、分類、信號機(jī)制與生物學(xué)功能
- MTT細(xì)胞增殖及細(xì)胞毒性檢測法的原理、應(yīng)用及實驗標(biāo)準(zhǔn)操作流程全解析
- MTS檢測試劑盒的檢測原理、優(yōu)勢及在生物醫(yī)學(xué)研究中的應(yīng)用
- 細(xì)胞轉(zhuǎn)染效率優(yōu)化指南：從質(zhì)粒比例到收獲時間五大關(guān)鍵要素解析
- Biolaminin 521 CTG細(xì)胞治療級別培養(yǎng)基質(zhì)在干細(xì)胞培養(yǎng)中應(yīng)用技術(shù)解析
Copyright(C) 1998-2026 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com